2020
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. Journal Of The American College Of Cardiology 2020, 75: 2352-2371. PMID: 32201335, PMCID: PMC7198856, DOI: 10.1016/j.jacc.2020.03.031.Peer-Reviewed Original ResearchConceptsHealth care workersCare workersCardiovascular ConsiderationsCardiovascular careCOVID-19Severe acute respiratory syndrome coronavirus 2Pre-existing cardiovascular diseaseAcute respiratory syndrome coronavirus 2Health systemRespiratory syndrome coronavirus 2Indirect cardiovascular complicationsCardiovascular side effectsAcute myocardial injurySyndrome coronavirus 2Coronavirus disease 2019Cardiovascular complicationsVenous thromboembolismMyocardial injuryCoronavirus 2Cardiovascular diseaseCardiovascular conditionsDisease 2019Severe diseaseSide effectsRapid triage
2001
Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma
Chen J, Radford M, Wang Y, Marciniak T, Krumholz H. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. Journal Of The American College Of Cardiology 2001, 37: 1950-1956. PMID: 11401137, DOI: 10.1016/s0735-1097(01)01225-6.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary diseaseBeta-blocker therapyAcute myocardial infarctionOne-year mortalityObstructive pulmonary diseasePulmonary diseaseElderly patientsSurvival benefitMyocardial infarctionSevere chronic obstructive pulmonary diseaseBeta-agonist therapyElderly AMI patientsSevere pulmonary diseaseCooperative Cardiovascular ProjectAsthma patientsClinical factorsAMI patientsMild diseaseClinical trialsDischarge useSevere diseaseAsthmaPatientsTherapyDisease